In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

A groundbreaking clinical trial has revealed that weight-loss injections marketed as Ozempic and Wegovy may significantly ...

Ozempic, known for aiding weight loss, could also help in treating alcohol addiction, as a study in JAMA Psychiatry suggests.

Ozempic is a once-weekly injection used to improve blood sugar levels in patients with Type 2 diabetes. It comes in doses of 0.25, 0.5, 1 and 2 milligrams (mg). The active ingredient, semaglutide ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

or 15 mg, or Ozempic at a dose of 1 mg. At 40 weeks, the mean HbA1c level with Mounjaro at a dose of 5 mg, 10 mg, and 15 mg was reduced by 2.01%, 2.24%, and 2.30%, respectively, compared to a ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...